BACKGROUND: The best treatment of fulminant or progressive cerebral venous and sinus thrombosis (CVST) despite dose-adjusted heparin remains controversial. Local thrombolysis has been successfully performed in several cases. In cases of impending herniation hemicraniectomy has been suggested as ultima ratio. We describe sequential escalation of therapy in "malignant" CVST. METHODS: Case report. RESULTS: We report a case of fulminant CVST in whom sequential escalation of therapy with intravenous heparin, local thrombolysis, and hemicraniectomy was necessitated by the progressive clinical course. The patient survived with a relatively good outcome. CONCLUSIONS: This first description on the combined treatment with local thrombolysis and hemicraniectomy illustrates that even in severely affected individuals, therapeutic nihilism is unwarranted and that all available therapeutic options including local thrombolysis and hemicraniectomy should be taken into consideration.
BACKGROUND: The best treatment of fulminant or progressive cerebral venous and sinus thrombosis (CVST) despite dose-adjusted heparin remains controversial. Local thrombolysis has been successfully performed in several cases. In cases of impending herniation hemicraniectomy has been suggested as ultima ratio. We describe sequential escalation of therapy in "malignant" CVST. METHODS: Case report. RESULTS: We report a case of fulminant CVST in whom sequential escalation of therapy with intravenous heparin, local thrombolysis, and hemicraniectomy was necessitated by the progressive clinical course. The patient survived with a relatively good outcome. CONCLUSIONS: This first description on the combined treatment with local thrombolysis and hemicraniectomy illustrates that even in severely affected individuals, therapeutic nihilism is unwarranted and that all available therapeutic options including local thrombolysis and hemicraniectomy should be taken into consideration.
Authors: K Einhäupl; M-G Bousser; S F T M de Bruijn; J M Ferro; I Martinelli; F Masuhr; J Stam Journal: Eur J Neurol Date: 2006-06 Impact factor: 6.089
Authors: Patrícia Canhão; José M Ferro; Arne G Lindgren; Marie-Germaine Bousser; Jan Stam; Fernando Barinagarrementeria Journal: Stroke Date: 2005-07-07 Impact factor: 7.914
Authors: Katayoun Vahedi; Jeannette Hofmeijer; Eric Juettler; Eric Vicaut; Bernard George; Ale Algra; G Johan Amelink; Peter Schmiedeck; Stefan Schwab; Peter M Rothwell; Marie-Germaine Bousser; H Bart van der Worp; Werner Hacke Journal: Lancet Neurol Date: 2007-03 Impact factor: 44.182
Authors: José M Ferro; Patrícia Canhão; Jan Stam; Marie-Germaine Bousser; Fernando Barinagarrementeria Journal: Stroke Date: 2004-02-19 Impact factor: 7.914
Authors: Christina M Kowoll; Julia Kaminski; Verena Weiß; Julian Bösel; Wenke Dietrich; Eric Jüttler; Julia Flechsenhar; Albrecht Guenther; Hagen B Huttner; Wolf-Dirk Niesen; Thomas Pfefferkorn; Ingo Schirotzek; Hauke Schneider; Thomas Liebig; Christian Dohmen Journal: Neurocrit Care Date: 2016-12 Impact factor: 3.210
Authors: Jonathan M Coutinho; Ako Dara Hama-Amin; Carmen Vleggeert-Lankamp; Jim A Reekers; Jan Stam; Marieke J H Wermer Journal: J Neurol Date: 2011-08-07 Impact factor: 4.849